Mechanisms and research progress of insect-derived medicines in intervention for ischemic stroke

昆虫源性药物干预缺血性中风的机制及研究进展

阅读:1

Abstract

Stroke is a severe neurological disorder caused by the rupture or blockage of blood vessels, leading to significant mortality and disability. Approximately 87 % of cases can be attributed to ischemic stroke. In China, ischemic stroke is the leading cause of death among adults. Current treatments for cerebral infarction mainly include thrombolysis, antiplatelet therapy, anticoagulation, and vasodilation. However, their efficacy in preventing or mitigating primary brain injury remains inadequate. In recent years, traditional Chinese medicine (TCM) has garnered increasing attention due to its proven efficacy and low toxicity. Numerous studies report that TCM formulas, extracts, and compound preparations exhibit pro-angiogenic activity. Insect-derived medicines, known for their actions in detoxification, eliminating pathogens, breaking blood stasis, resolving blood stasis, dispelling wind, and unblocking collaterals, show favorable efficacy in treating ischemic stroke. This paper summarizes several insect-derived medicines and their active components, elucidates their mechanisms of action in antithrombosis, neuroprotection, anti-inflammation, and antioxidation, and discusses current clinical applications and future research directions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。